down arrow

Sight Sciences, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US82657M1053
USD
8.34
0.04 (0.48%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

8.188.61

52 Week

2.038.61
Valuation
Technical
Day's Volume

CASH

108.21 k

Shareholding (Mar 2025)

FII

16.54%

Held by 43 FIIs

DII

59.6%

Held by 17 DIIs

Promoter

9.94%

How big is Sight Sciences, Inc.?

22-Jun-2025

As of Jun 18, Sight Sciences, Inc. has a market capitalization of 208.36 million and reported net sales of 78.11 million with a net profit of -49.40 million over the latest four quarters. Shareholder's funds are at 87.52 million, and total assets are 142.84 million as of Dec 24.

As of Jun 18, Sight Sciences, Inc. has a market capitalization of 208.36 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of Net Sales for the latest four quarters is 78.11 million, while the sum of Net Profit for the same period is -49.40 million.<BR><BR>As of Dec 24, the reporting period shows Shareholder's Funds at 87.52 million and Total Assets at 142.84 million.

Read More

What does Sight Sciences, Inc. do?

22-Jun-2025

Sight Sciences, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $18 million and a net loss of $14 million as of March 2025. The company has a market cap of $208.36 million and does not pay dividends.

Overview:<BR>Sight Sciences, Inc. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 18 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -14 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 208.36 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.88 <BR>Return on Equity: -63.63% <BR>Price to Book: 2.68<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Read More

Should I buy, sell or hold Sight Sciences, Inc.?

22-Jun-2025

Is Sight Sciences, Inc. technically bullish or bearish?

20-Sep-2025

As of September 12, 2025, Sight Sciences, Inc. is in a mildly bearish trend, with weekly indicators signaling bearishness despite some daily moving averages being mildly bullish, and the stock has underperformed the S&P 500 by -43.75% compared to its 17.14% return over the past year.

As of 12 September 2025, the technical trend for Sight Sciences, Inc. has changed from sideways to mildly bearish. The current stance is mildly bearish, driven by weekly MACD and KST indicators both signaling mild bearishness, along with Bollinger Bands indicating a bearish trend. The daily moving averages are mildly bullish, which provides some counterbalance but is outweighed by the overall bearish indicators. The stock has underperformed the S&P 500 significantly over the past year, with a return of -43.75% compared to the S&P 500's 17.14%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Flat results in Jun 25

  • ROCE(HY) Lowest at -57.1%
2

Risky - Negative EBITDA

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 193 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.87

stock-summary
Return on Equity

-70.00%

stock-summary
Price to Book

2.76

Revenue and Profits:
Net Sales:
20 Million
(Quarterly Results - Jun 2025)
Net Profit:
-12 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
119.47%
0%
119.47%
6 Months
107.46%
0%
107.46%
1 Year
116.06%
0%
116.06%
2 Years
187.59%
0%
187.59%
3 Years
-30.09%
0%
-30.09%
4 Years
-60.1%
0%
-60.1%
5 Years
0%
0%
0.0%

Sight Sciences, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Sight Sciences, Inc. Hits New 52-Week High at USD 5.86

Sight Sciences, Inc. Hits New 52-Week High at USD 5.86

Sight Sciences, Inc. has achieved a new 52-week high of USD 5.86, significantly up from its low of USD 2.03. With a market capitalization of USD 193 million, the company, despite losses and a negative return on equity, has outperformed the S&P 500 over the past year.

Read More

Is Sight Sciences, Inc. technically bullish or bearish?

As of 12 September 2025, the technical trend for Sight Sciences, Inc. has changed from sideways to mildly bearish. The current stance is mildly bearish, driven by weekly MACD and KST indicators both signaling mild bearishness, along with Bollinger Bands indicating a bearish trend. The daily moving averages are mildly bullish, which provides some counterbalance but is outweighed by the overall bearish indicators. The stock has underperformed the S&P 500 significantly over the past year, with a return of -43.75% compared to the S&P 500's 17.14%....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
50.14%
EBIT Growth (5y)
-199.36%
EBIT to Interest (avg)
-12.78
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.88
Sales to Capital Employed (avg)
0.57
Tax Ratio
0.53%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
65.14%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.80
EV to EBIT
-2.99
EV to EBITDA
-3.02
EV to Capital Employed
16.51
EV to Sales
1.90
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-552.17%
ROE (Latest)
-63.63%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 29 Schemes (13.91%)

Foreign Institutions

Held by 43 Foreign Institutions (16.54%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 12.00% vs -8.38% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 16.20% vs -20.34% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "19.60",
          "val2": "17.50",
          "chgp": "12.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-11.50",
          "val2": "-13.70",
          "chgp": "16.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.30",
          "val2": "1.30",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-11.90",
          "val2": "-14.20",
          "chgp": "16.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-596.40%",
          "val2": "-791.60%",
          "chgp": "19.52%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -1.48% vs 13.74% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 7.21% vs 35.61% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "79.90",
          "val2": "81.10",
          "chgp": "-1.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-49.80",
          "val2": "-56.70",
          "chgp": "12.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.70",
          "val2": "5.40",
          "chgp": "-12.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-51.50",
          "val2": "-55.50",
          "chgp": "7.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-632.70%",
          "val2": "-706.60%",
          "chgp": "7.39%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
19.60
17.50
12.00%
Operating Profit (PBDIT) excl Other Income
-11.50
-13.70
16.06%
Interest
1.30
1.30
Exceptional Items
0.00
0.00
Consolidate Net Profit
-11.90
-14.20
16.20%
Operating Profit Margin (Excl OI)
-596.40%
-791.60%
19.52%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 12.00% vs -8.38% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 16.20% vs -20.34% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
79.90
81.10
-1.48%
Operating Profit (PBDIT) excl Other Income
-49.80
-56.70
12.17%
Interest
4.70
5.40
-12.96%
Exceptional Items
-2.00
0.00
Consolidate Net Profit
-51.50
-55.50
7.21%
Operating Profit Margin (Excl OI)
-632.70%
-706.60%
7.39%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -1.48% vs 13.74% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 7.21% vs 35.61% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Sight Sciences, Inc. stock-summary
stock-summary
Sight Sciences, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."